Clément Orczyk

Associate Professor of Urology Honorary Consultant Urological Surgeon

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Clément Orczyk is an Associate Professor of Urology and Honorary Consultant Urological Surgeon at University College London, UK. His research focuses on advancements in prostate cancer diagnosis and treatment, particularly through the application of magnetic resonance imaging and focal therapy. Recent publications include studies on the diagnostic utility of multiparametric MRI, risk stratification in early prostate cancer, and outcomes following focal ablative therapy for localized clinically significant prostate cancer.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Taimur T. Shah

UNITED KINGDOM

View details

Caroline M Moore

University College London

UNITED KINGDOM

View details

mathias winkler

Visiting Reader Urology

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Clément Orczyk

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility Phenomenon

The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE)

The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial

External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.

Re: Thomas Bommelaere, Arnauld Villers, Philippe Puech, et al. Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted Biopsy. Eur Urol Open Sci 2022;41:24-34.

Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience.

Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.

A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.

Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.

Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients 70 Years: A Multi-institute, Multi-energy 15-Year Experience

Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience

Diagnostic potential of radiological apical tumor involvement.

Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.

Collaborators (3)

Taimur T. Shah

Caroline M Moore

mathias winkler

Make your next move.